FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076338762> ?p ?o ?g. }

• W2076338762 endingPage "50" @default.
• W2076338762 startingPage "43" @default.
• W2076338762 abstract "The therapeutic use of the immunosuppressive agent cyclosporin A (CsA) is associated with arterial hypertension and increased risk of thromboembolism. Impaired endothelium-mediated relaxation is one of the main hypotheses explaining the CsA-induced vascular hyper-reactivity. Since nitric oxide (NO) modulates both vascular and platelet activity, we studied the effects of CsA on the levels of arterial and platelet NO as well as 3',5'-cyclic guanosine monophosphate (cGMP) levels which are influenced by NO. An animal model of CsA-induced hypertension was used. Wistar rats were treated with a clinically relevant, oral dose of 5 mg/kg CsA, daily, for 4 weeks. CsA increased both systolic and diastolic blood pressures compared to non-treated rats (P < 0.01). Nitrite, a NO metabolite, decreased in the entire aorta wall (30%, P < 0.05) and in the aorta wall without the endothelial layer (70 %, P < 0.05) in CsA-treated vs. control groups. cGMP content was also decreased in the CsA-treated group (67%, P < 0.01) vs. control. Taken together, these results suggest a defect on the endothelial NO generation, acceleration of breakdown and/or consumption of NO, as well as marked alterations directly on cGMP metabolism. Conversely, platelet nitrite and cGMP content significantly increased in the CsA-treated rats, which was also observed in in vitro studies of platelet nitrite release following CsA treatment. This suggests a platelet self-regulation mechanism against CsA-induced platelet hyper-reactivity, which, in turn, could compensate vascular impairment." @default.
• W2076338762 created "2016-06-24" @default.
• W2076338762 creator A5012871653 @default.
• W2076338762 creator A5034460586 @default.
• W2076338762 creator A5037887576 @default.
• W2076338762 creator A5043517773 @default.
• W2076338762 creator A5068760732 @default.
• W2076338762 creator A5069691205 @default.
• W2076338762 date "2003-02-01" @default.
• W2076338762 modified "2023-09-27" @default.
• W2076338762 title "Impairment of vascular and platelet levels of nitric oxide and cyclic guanosine-3',5'-monophosphate in cyclosporin A-induced hypertensive rats" @default.
• W2076338762 cites W1978943215 @default.
• W2076338762 cites W1980859407 @default.
• W2076338762 cites W1990802251 @default.
• W2076338762 cites W1997271863 @default.
• W2076338762 cites W2000469906 @default.
• W2076338762 cites W2001918921 @default.
• W2076338762 cites W2005105736 @default.
• W2076338762 cites W2011935821 @default.
• W2076338762 cites W2012616491 @default.
• W2076338762 cites W2029685594 @default.
• W2076338762 cites W2039844911 @default.
• W2076338762 cites W2039949381 @default.
• W2076338762 cites W2044527055 @default.
• W2076338762 cites W2045079760 @default.
• W2076338762 cites W2046265270 @default.
• W2076338762 cites W2048140772 @default.
• W2076338762 cites W2055289360 @default.
• W2076338762 cites W2061210418 @default.
• W2076338762 cites W2062864110 @default.
• W2076338762 cites W2066750925 @default.
• W2076338762 cites W2071649220 @default.
• W2076338762 cites W2076720226 @default.
• W2076338762 cites W2085745007 @default.
• W2076338762 cites W2089941924 @default.
• W2076338762 cites W2098915731 @default.
• W2076338762 cites W2099101337 @default.
• W2076338762 cites W2115690116 @default.
• W2076338762 cites W2122830164 @default.
• W2076338762 cites W2127719945 @default.
• W2076338762 cites W2127906757 @default.
• W2076338762 cites W2128635872 @default.
• W2076338762 cites W2137485360 @default.
• W2076338762 cites W2145050928 @default.
• W2076338762 cites W2162253577 @default.
• W2076338762 cites W2313326603 @default.
• W2076338762 cites W2320368977 @default.
• W2076338762 cites W2324470778 @default.
• W2076338762 cites W4234022131 @default.
• W2076338762 cites W4255940022 @default.
• W2076338762 doi "https://doi.org/10.1046/j.1472-8206.2003.00116.x" @default.
• W2076338762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12588629" @default.
• W2076338762 hasPublicationYear "2003" @default.
• W2076338762 type Work @default.
• W2076338762 sameAs 2076338762 @default.
• W2076338762 citedByCount "6" @default.
• W2076338762 crossrefType "journal-article" @default.
• W2076338762 hasAuthorship W2076338762A5012871653 @default.
• W2076338762 hasAuthorship W2076338762A5034460586 @default.
• W2076338762 hasAuthorship W2076338762A5037887576 @default.
• W2076338762 hasAuthorship W2076338762A5043517773 @default.
• W2076338762 hasAuthorship W2076338762A5068760732 @default.
• W2076338762 hasAuthorship W2076338762A5069691205 @default.
• W2076338762 hasConcept C120770815 @default.
• W2076338762 hasConcept C126322002 @default.
• W2076338762 hasConcept C134018914 @default.
• W2076338762 hasConcept C178790620 @default.
• W2076338762 hasConcept C185592680 @default.
• W2076338762 hasConcept C2776179834 @default.
• W2076338762 hasConcept C2776384668 @default.
• W2076338762 hasConcept C2776992346 @default.
• W2076338762 hasConcept C2777995097 @default.
• W2076338762 hasConcept C2780994212 @default.
• W2076338762 hasConcept C3018697912 @default.
• W2076338762 hasConcept C519581460 @default.
• W2076338762 hasConcept C55493867 @default.
• W2076338762 hasConcept C71924100 @default.
• W2076338762 hasConcept C89560881 @default.
• W2076338762 hasConceptScore W2076338762C120770815 @default.
• W2076338762 hasConceptScore W2076338762C126322002 @default.
• W2076338762 hasConceptScore W2076338762C134018914 @default.
• W2076338762 hasConceptScore W2076338762C178790620 @default.
• W2076338762 hasConceptScore W2076338762C185592680 @default.
• W2076338762 hasConceptScore W2076338762C2776179834 @default.
• W2076338762 hasConceptScore W2076338762C2776384668 @default.
• W2076338762 hasConceptScore W2076338762C2776992346 @default.
• W2076338762 hasConceptScore W2076338762C2777995097 @default.
• W2076338762 hasConceptScore W2076338762C2780994212 @default.
• W2076338762 hasConceptScore W2076338762C3018697912 @default.
• W2076338762 hasConceptScore W2076338762C519581460 @default.
• W2076338762 hasConceptScore W2076338762C55493867 @default.
• W2076338762 hasConceptScore W2076338762C71924100 @default.
• W2076338762 hasConceptScore W2076338762C89560881 @default.
• W2076338762 hasIssue "1" @default.
• W2076338762 hasLocation W20763387621 @default.
• W2076338762 hasLocation W20763387622 @default.
• W2076338762 hasOpenAccess W2076338762 @default.
• W2076338762 hasPrimaryLocation W20763387621 @default.

• next